GNH USA

Europe — EMA

Glypvilo

Glypvilo (vildagliptin) is an oral DPP‑4 inhibitor used in the EU for type 2 diabetes management; learn uses, side effects, precautions, and drug interactions.

Vildagliptin

Request sourcing

1
Pack/s

What is Vildagliptin?

Glypvilo is a prescription medication that contains the active ingredient vildagliptin, supplied as oral tablets (strength not specified). It belongs to the dipeptidyl peptidase‑4 (DPP‑4) inhibitor class and is marketed in the European Union for the management of type 2 diabetes mellitus.

What is Vildagliptin used for?

Glypvilo is indicated for the treatment of adults with type 2 diabetes mellitus, typically as part of a comprehensive diabetes management plan. It may be used alone or in combination with other antidiabetic agents.

- Improves glycemic control when added to diet and exercise. - Can be combined with metformin for enhanced effect. - May be used with sulfonylureas in patients not achieving target glucose levels. - Suitable for patients who require an oral DPP‑4 inhibitor. - Often prescribed when other oral agents are insufficient.

What are the side effects of Vildagliptin?

Side effects of Glypvilo vary in frequency and severity. Patients should be aware of both common and serious reactions.

Common: - Upper respiratory tract infection - Headache - Dizziness - Nausea - Diarrhea - Skin rash

Serious: - Severe allergic reactions (anaphylaxis, angioedema) - Pancreatitis symptoms (persistent abdominal pain) - Hepatotoxicity (elevated liver enzymes) - Severe hypoglycemia when combined with insulin or sulfonylureas

What precautions apply to Vildagliptin?

Before starting Glypvilo, certain health considerations should be reviewed to ensure safe use.

- Assess renal function; dose adjustment may be needed in impairment. - Monitor liver enzymes periodically during therapy. - Use caution in patients with a history of pancreatitis. - Evaluate for potential hypersensitivity reactions. - Educate patients on recognizing signs of hypoglycemia, especially when used with insulin or sulfonylureas. - Discuss pregnancy and lactation status with a healthcare professional.

What does Vildagliptin interact with?

Glypvilo can interact with several drug classes, requiring attention to avoid adverse effects.

Avoid: - Strong CYP3A4 inhibitors (e.g., ketoconazole) that may increase vildagliptin exposure. - Concurrent use with other DPP‑4 inhibitors.

Use with caution: - Insulin or sulfonylureas (risk of hypoglycemia). - Diuretics that may affect renal clearance. - NSAIDs that could impact renal function. - Rifampin (possible reduction in efficacy).

Frequently asked questions

What is the mechanism of action of Glypvilo (vildagliptin)?+
Glypvilo inhibits the dipeptidyl peptidase‑4 (DPP‑4) enzyme, which increases endogenous incretin hormones (GLP‑1 and GIP). This enhances glucose‑dependent insulin secretion and reduces glucagon release, helping to lower blood glucose levels.
Can Glypvilo be used as a first‑line therapy for type 2 diabetes?+
Glypvilo may be prescribed as initial therapy in patients who cannot tolerate metformin or when a DPP‑4 inhibitor is preferred, but treatment decisions should be individualized by a healthcare professional.
Is dose adjustment required for Glypvilo in patients with kidney disease?+
Yes, renal function should be evaluated before initiating Glypvilo, and dose adjustments may be necessary for patients with moderate to severe renal impairment.
What are common side effects of Glypvilo?+
Common adverse effects include upper respiratory tract infections, headache, dizziness, nausea, diarrhea, and mild skin rash.
What serious adverse reactions should patients be aware of while taking Glypvilo?+
Serious reactions can include severe allergic responses (anaphylaxis, angioedema), signs of pancreatitis (persistent abdominal pain), liver enzyme elevations, and severe hypoglycemia when combined with insulin or sulfonylureas.
Should Glypvilo be taken with food?+
Glypvilo can be taken with or without food; however, consistent administration with respect to meals may help maintain stable drug levels.
Can Glypvilo be combined with metformin?+
Yes, Glypvilo is often prescribed in combination with metformin to improve glycemic control when metformin alone does not achieve target glucose levels.
What monitoring is recommended during Glypvilo therapy?+
Regular monitoring of blood glucose, renal function, and liver enzymes is recommended, along with periodic assessment for signs of pancreatitis or hypersensitivity.
Is Glypvilo safe during pregnancy or breastfeeding?+
The safety of Glypvilo during pregnancy and lactation has not been fully established; it should only be used if the potential benefit justifies the potential risk, under medical supervision.
What should I do if I miss a dose of Glypvilo?+
If a dose is missed, take it as soon as remembered unless it is near the time of the next scheduled dose. Do not double the dose; continue with the regular dosing schedule.
Are there any foods or beverages that should be avoided while taking Glypvilo?+
There are no specific dietary restrictions, but patients should maintain a balanced diet and avoid excessive alcohol, which can affect blood glucose control.
How does Glypvilo differ from other DPP‑4 inhibitors?+
Glypvilo contains vildagliptin, which has a similar efficacy profile to other DPP‑4 inhibitors but may differ in dosing frequency, pharmacokinetics, and individual patient tolerability.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Vildagliptin
Route
Oral Use
Manufacturer
Krka, D.D., Novo Mesto
Origin
EU

Related products